Approvals/TGA/EVOTAZ atazanavir/cobicistat 300 mg/150 mg film coated tablets bottle

Approved

STANDARD

EVOTAZ atazanavir/cobicistat 300 mg/150 mg film coated tablets bottle

Bristol-Myers Squibb Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: fbed5809fdbac7fc
Product Name: EVOTAZ atazanavir/cobicistat 300 mg/150 mg film coated tablets bottle
Artg Id: 229476
Artg Name: EVOTAZ atazanavir/cobicistat 300 mg/150 mg film coated tablets bottle
Sponsor: Bristol-Myers Squibb Australia Pty Ltd
Company Detail Path: /organization/bristol-myers-squibb-australia-pty-ltd
Artg Date: 2015-09-23
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/954ceebf8063720e1e7389f53e24c243.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/2966beaad0c429a8785a78182a7ec2d1.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

fbed5809fdbac7fc

Type

Standard